Fulgent Genetics Operating Margin 2015-2025 | FLGT
Current and historical operating margin for Fulgent Genetics (FLGT) over the last 10 years. The current operating profit margin for Fulgent Genetics as of June 30, 2025 is -8.40%.
| Fulgent Genetics Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-06-30 | $0.30B | $-0.07B | -24.09% |
| 2025-03-31 | $0.29B | $-0.07B | -24.66% |
| 2024-12-31 | $0.28B | $-0.07B | -26.15% |
| 2024-09-30 | $0.28B | $-0.21B | -75.18% |
| 2024-06-30 | $0.29B | $-0.19B | -65.98% |
| 2024-03-31 | $0.29B | $-0.19B | -67.01% |
| 2023-12-31 | $0.29B | $-0.20B | -67.59% |
| 2023-09-30 | $0.29B | $-0.08B | -28.57% |
| 2023-06-30 | $0.31B | $-0.08B | -26.62% |
| 2023-03-31 | $0.37B | $-0.05B | -13.42% |
| 2022-12-31 | $0.62B | $0.18B | 28.76% |
| 2022-09-30 | $0.80B | $0.37B | 45.58% |
| 2022-06-30 | $0.93B | $0.53B | 56.76% |
| 2022-03-31 | $0.95B | $0.61B | 64.05% |
| 2021-12-31 | $0.99B | $0.68B | 68.08% |
| 2021-09-30 | $1.04B | $0.75B | 72.49% |
| 2021-06-30 | $0.91B | $0.66B | 72.09% |
| 2021-03-31 | $0.77B | $0.56B | 72.45% |
| 2020-12-31 | $0.42B | $0.29B | 68.96% |
| 2020-09-30 | $0.14B | $0.07B | 48.15% |
| 2020-06-30 | $0.04B | $0.00B | 6.98% |
| 2020-03-31 | $0.03B | 0 | 0.00% |
| 2019-12-31 | $0.03B | 0 | 0.00% |
| 2019-09-30 | $0.03B | $0.00B | -3.45% |
| 2019-06-30 | $0.03B | $0.00B | -16.00% |
| 2019-03-31 | $0.02B | $-0.01B | -22.73% |
| 2018-12-31 | $0.02B | $-0.01B | -22.73% |
| 2018-09-30 | $0.02B | $-0.01B | -30.00% |
| 2018-06-30 | $0.02B | $-0.01B | -31.58% |
| 2018-03-31 | $0.02B | $-0.01B | -26.32% |
| 2017-12-31 | $0.02B | $0.00B | -15.79% |
| 2017-09-30 | $0.02B | 0 | 0.00% |
| 2017-06-30 | $0.02B | 0 | 0.00% |
| 2017-03-31 | $0.02B | $0.00B | 5.00% |
| 2016-12-31 | $0.02B | 0 | 0.00% |
| 2016-06-30 | $0.01B | $0.00B | 10.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.679B | $0.283B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.991B | 53.84 |
| Tempus AI (TEM) | United States | $13.179B | 0.00 |
| Doximity (DOCS) | United States | $12.725B | 56.62 |
| Hims & Hers Health (HIMS) | United States | $9.572B | 78.43 |
| IRhythm Technologies (IRTC) | United States | $5.461B | 0.00 |
| Hinge Health (HNGE) | United States | $4.399B | 0.00 |
| Privia Health (PRVA) | United States | $2.828B | 209.45 |
| Inspire Medical Systems (INSP) | United States | $2.771B | 40.73 |
| Heartflow (HTFL) | $2.557B | 0.00 | |
| Phreesia (PHR) | United States | $1.884B | 0.00 |
| Enovis (ENOV) | United States | $1.766B | 9.34 |
| 10x Genomics (TXG) | United States | $1.744B | 0.00 |
| Omnicell (OMCL) | United States | $1.497B | 28.84 |
| Schrodinger (SDGR) | United States | $1.436B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 61.08 |
| Clover Health Investments (CLOV) | United States | $1.343B | 0.00 |
| Claritev (CTEV) | United States | $1.135B | 0.00 |
| Evolent Health (EVH) | United States | $1.134B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.652B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.481B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 133.00 |
| Butterfly Network (BFLY) | United States | $0.405B | 0.00 |
| Carlsmed (CARL) | United States | $0.353B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.53 |
| Outset Medical (OM) | United States | $0.247B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.239B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.234B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.213B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.195B | 0.00 |
| CapsoVision (CV) | United States | $0.175B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.168B | 0.00 |
| CareCloud (CCLD) | United States | $0.163B | 7.38 |
| American Well (AMWL) | United States | $0.111B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.077B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| Pulmonx (LUNG) | United States | $0.070B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| 111 (YI) | China | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.046B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| PROFUSA (PFSA) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |